NOTA:FRA
Novartis AG
145,00 €
arrow_upward
+0,69%(+1,00) 1D
30 tet, 10:00:00 m.d., GMT+1 · EUR
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për NOTA...
Hap
140,00 €
I lartë
145,00 €
I ulët
140,00 €
Kapitalizimi i tregut
326,00Â mld
Vëllimi mesatar
12,00
Vëllimi
0,00
Maksimumi 52-javor
145,00 €
Minimumi 52-javor
102,50 €
Numri i punonjësve
75 mijë
Hap
140,00 €
I lartë
145,00 €
I ulët
140,00 €
Kapitalizimi i tregut
326,00Â mld
Vëllimi mesatar
12,00
Vëllimi
0,00
Maksimumi 52-javor
145,00 €
Minimumi 52-javor
102,50 €
Numri i punonjësve
75 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
WSJ
·
1 orë më parë
Novartis Raises Guidance Despite Drug-Trial Setbacks Hitting Profit
Seeking Alpha
·
4 orë më parë
Novartis: Q3 2026 Earnings Confirm 'Hold' Recommendation Based On Balanced Approach (NVS)
BioPharma Dive
·
1 ditë më parë
Earnings roundup: Lilly’s unwavering momentum, Novartis’ rebound and GSK’s waiting game
kalkine.ca
·
2 ditë më parë
Novartis (NYSE:NVS) Earnings: How Can Kisqali's 37% Growth Offset Entresto's Fall After a Guidance Raise?
Profili
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Rreth Novartis AG
Drejtori ekzekutivVasant Narasimhan
Punonjësit75,3 mijë
Themeluar më7 mar 1996
SeliaBasel, Basel City, Zvicër
Sektori-
Uebsajtinovartis.com